This American company is based in Columbia, Maryland and is listed part of the Russell 2000 Index. The foundation of the business is anchored on the research of Dr. Arnold Caplan at the Case Western University. Together with two co-founders Kevin Kimberlin and Peter Freidli, they founded the business in 1992. It has remained in the forefront in the research and development of mesenchymal stem cell (MSC) science. With more than 20 years of experience, strong understanding and research in this field of interest, they have become the first company to market the world’s first approved stem cell drug.
They remain to be the leading stem cell company today. Osiris’ common stocks are made publicly available through the NASDAQ under the symbol OSIR.